Primary Cervical Malignant Melanoma: 2 Cases and a Literature Review
Authors:
- Anqiang YangAYAnqiang Yang
- Ying ZhangYZYing Zhang
- Lin TaoLTLin Tao
- Hong ZouHZHong Zou
- Yan RenYRYan Ren
- Weihua LiangWLWeihua Liang
- Jinfang JiangJJJinfang Jiang
- Jin ZhaoJZJin Zhao
- Wenjie ZhangWZWenjie Zhang
- Feng LiFLFeng Li
- Wei JiaWJWei Jia
- 1 March 2019
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 38 (2) , 196-203
Abstract
Primary cervical malignant melanoma (MM) is an extremely rare tumor, and we are only aware of 44 reported cases. Further information is needed with regard to this disease’s clinicopathologic features. Two patients (55 and 81 yr old) with postmenopausal vaginal bleeding were diagnosed with primary cervical MM on the basis of hematoxylin-eosin staining and immunohistochemistry findings. Our literature review revealed that the average age in cases of primary cervical MM was 59 yr (range, 34–81 yr); 93% of patients presented with vaginal bleeding, and 82% of patients were diagnosed at an early clinical stage (International Federation of Gynecology and Obstetrics stages I–II). Primary cervical MM is an extremely rare cervical tumor and is associated with a poor prognosis. Histologic morphology and immunohistochemistry are very important considerations for diagnosing this disease, which must be differentiated from cervical undifferentiated carcinoma, leiomyosarcoma, and malignant peripheral schwannoma.Keywords
This publication has 13 references indexed in Scilit:
- Primary Malignant Melanoma of Uterine CervixThe Journal of Obstetrics and Gynecology of India, 2013
- A literature overview of primary cervical malignant melanoma: An exceedingly rare cancerCritical Reviews in Oncology/Hematology, 2012
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaNew England Journal of Medicine, 2011
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future ProspectsThe Oncologist, 2011
- Management of primary melanoma of the female urogenital tractThe Lancet Oncology, 2008
- Management of melanomas of the female genital tractCurrent Opinion in Oncology, 2008
- Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanomaAnnals of Oncology, 2006
- Incidence of noncutaneous melanomas in the U.S.Cancer, 2005
- Morphological and immunophenotypic variations in malignant melanomaHistopathology, 2000
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998